BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 11859975)

  • 1. The prognostic value of tumor markers in patients with glioblastoma multiforme: analysis of 32 patients and review of the literature.
    Reavey-Cantwell JF; Haroun RI; Zahurak M; Clatterbuck RE; Parker RJ; Mehta R; Fruehauf JP; Brem H
    J Neurooncol; 2001 Dec; 55(3):195-204. PubMed ID: 11859975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multivariate analysis for prognostic significance of histologic subtype, GST-pi, MDR-1, and p53 in stages II-IV ovarian cancer.
    Ikeda K; Sakai K; Yamamoto R; Hareyama H; Tsumura N; Watari H; Shimizu M; Minakami H; Sakuragi N
    Int J Gynecol Cancer; 2003; 13(6):776-84. PubMed ID: 14675314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of Ki-67 expression, ploidy and S-phase fraction in patients with pancreatic cancer.
    Lundin J; Nordling S; von Boguslawsky K; Roberts PJ; Haglund C
    Anticancer Res; 1995; 15(6B):2659-68. PubMed ID: 8669843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of Ki-67 (MIB-1) and p53 in ependymomas.
    Suzuki S; Oka H; Kawano N; Tanaka S; Utsuki S; Fujii K
    Brain Tumor Pathol; 2001; 18(2):151-4. PubMed ID: 11908872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ki-67, p53, Er-receptors, ploidy and S-phase as prognostic factors in T1 node negative breast cancer.
    Railo M; Lundin J; Haglund C; von Smitten K; von Boguslawsky K; Nordling S
    Acta Oncol; 1997; 36(4):369-74. PubMed ID: 9247096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of Ki67, p53 and epidermal growth factor receptor immunostaining in human glioblastomas.
    Bouvier-Labit C; Chinot O; Ochi C; Gambarelli D; Dufour H; Figarella-Branger D
    Neuropathol Appl Neurobiol; 1998 Oct; 24(5):381-8. PubMed ID: 9821169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of an apoptotic index and apoptosis/proliferation ratio for patients with high-grade astrocytomas.
    Kuriyama H; Lamborn KR; O'Fallon JR; Iturria N; Sebo T; Schaefer PL; Scheithauer BW; Buckner JC; Kuriyama N; Jenkins RB; Israel MA
    Neuro Oncol; 2002 Jul; 4(3):179-86. PubMed ID: 12084348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic study of 85 similarly treated patients with anaplastic astrocytic tumors. An analysis of DNA content (ploidy), cellular proliferation, and p53 expression.
    Perry A; Jenkins RB; O'Fallon JR; Schaefer PL; Kimmel DW; Mahoney MR; Scheithauer BW; Smith SM; Hill EM; Sebo TJ; Levitt R; Krook J; Tschetter LK; Morton RF; Buckner JC
    Cancer; 1999 Aug; 86(4):672-83. PubMed ID: 10440696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic relevance of TP53 mutations, p53 protein, Ki-67 index and conventional histological grading in oligodendrogliomas.
    Hagel C; Krog B; Laas R; Stavrou DK
    J Exp Clin Cancer Res; 1999 Sep; 18(3):305-9. PubMed ID: 10606174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of glutathione S-transferase pi expression and subcellular localization in human gliomas.
    Ali-Osman F; Brunner JM; Kutluk TM; Hess K
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2253-61. PubMed ID: 9815622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High cyclin E/low p27Kip1 expression is associated with poor prognosis in astrocytomas.
    Tamiya T; Mizumatsu S; Ono Y; Abe T; Matsumoto K; Furuta T; Ohmoto T
    Acta Neuropathol; 2001 Apr; 101(4):334-40. PubMed ID: 11355304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor marker expression is predictive of survival in patients with esophageal cancer.
    Aloia TA; Harpole DH; Reed CE; Allegra C; Moore MB; Herndon JE; D'Amico TA
    Ann Thorac Surg; 2001 Sep; 72(3):859-66. PubMed ID: 11565671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synovial sarcoma: immunohistochemical expression of P-glycoprotein and glutathione S transferase-pi and clinical drug resistance.
    Lopes JM; Bruland OS; Bjerkehagen B; Silva MC; Holm R; Pettersen EO; Solheim OP; Sobrinho-Simões M; Nesland JM
    Pathol Res Pract; 1997; 193(1):21-36. PubMed ID: 9112270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Appraisal of intratumoral microvessel density, MIB-1 score, DNA content, and p53 protein expression as prognostic indicators in patients with locally confined renal cell carcinoma.
    Gelb AB; Sudilovsky D; Wu CD; Weiss LM; Medeiros LJ
    Cancer; 1997 Nov; 80(9):1768-75. PubMed ID: 9351546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of p53 in glioblastoma multiforme cells: relationship to survival, proliferation and glycosylation.
    Ehrmann J; Kolár Z; Kala M; Vojtĕsek B; Komenda S
    Cesk Patol; 1995 Aug; 31(3):87-91. PubMed ID: 9444787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic relevance of NG2/CSPG4, CD44 and Ki-67 in patients with glioblastoma.
    Tsidulko AY; Kazanskaya GM; Kostromskaya DV; Aidagulova SV; Kiselev RS; Volkov AM; Kobozev VV; Gaitan AS; Krivoshapkin AL; Grigorieva EV
    Tumour Biol; 2017 Sep; 39(9):1010428317724282. PubMed ID: 28945172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of p53, glutathione S-transferase-pi, and Bcl-2 proteins and benefit from adjuvant radiotherapy in breast cancer.
    Silvestrini R; Veneroni S; Benini E; Daidone MG; Luisi A; Leutner M; Maucione A; Kenda R; Zucali R; Veronesi U
    J Natl Cancer Inst; 1997 May; 89(9):639-45. PubMed ID: 9150188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of immunohistochemical Ki-67 and p53 determinations as predictive factors of outcome in renal cell carcinoma.
    Rioux-Leclercq N; Turlin B; Bansard J; Patard J; Manunta A; Moulinoux JP; Guillé F; Ramée MP; Lobel B
    Urology; 2000 Apr; 55(4):501-5. PubMed ID: 10736491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of DNA cytometry in 281 premenopausal patients with lymph node negative breast carcinoma randomized in a control trial: multivariate analysis with Ki-67 index, mitotic count, and microvessel density.
    Mandard AM; Denoux Y; Herlin P; Duigou F; van De Vijver MJ; Clahsen PC; van Den Broek L; Sahmoud TM; Henry-Amar M; van De Velde CJ
    Cancer; 2000 Oct; 89(8):1748-57. PubMed ID: 11042570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accumulation of p53 and Ki-67 expression do not predict survival in patients with fibrillary astrocytomas or the response of these tumors to radiotherapy.
    Mastronardi L; Puzzilli F; Guiducci A
    Neurosurgery; 1998 Dec; 43(6):1496. PubMed ID: 9848870
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.